BCRX FY 2010 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M-14.9% YoY

Gross Profit

$63M99.9% margin

Operating Income

-$33M-52.3% margin

Net Income

-$33M-51.5% margin

EPS (Diluted)

$-0.73

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$111M

Total Liabilities

$44M

Stockholders' Equity

$67M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$75M	-14.9%
Gross Profit	$63M	$70M	-9.5%
Operating Income	-$33M	-$14M	-141.9%
Net Income	-$33M	-$13M	-143.3%